[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Near-infrared Imaging Market by Product (Imaging System, Probe, Dye (Organic, Nanoparticle)), Procedure (Cancer, CVD, GI, OB/GYN), Application (Preclinical, Clinical, Medical), End User (Hospital, Pharma, Research Lab) & Region - Global Forecast to 2028

June 2023 | 233 pages | ID: N963F7D8028EN
MarketsandMarkets

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global near infrared imaging market is projected to reach USD 1.9 billion by 2028 from USD 1.0 billion in 2023, at a CAGR of 14.0% from 2023 to 2028. Factors such as the high incidence/prevalence of target diseases, growing number of diagnostic imaging centers/procedures, increasing awareness about the benefits of early diagnosis of diseases, and the rapid adoption of technologically advanced NIR modalities are responsible for the increasing growth of this market.

“The near-infrared fluorescence imaging sub-systems segment of NIR devices segment held the largest share of the market in 2022”

Based on product, the near-infrared imaging market is segmented into NIR devices, NIR imaging agents/probes and NIR dyes. The NIR devices segment of the market is further divided into near-infrared fluorescence imaging systems and near-infrared fluorescence & bioluminescence imaging systems. The near-infrared fluorescence imaging systems subsegment held a major share in the market. Advantages offered by near-infrared fluorescence imaging systems, such as high sensitivity, high-image resolution, and real-time image guidance during surgeries, are driving the growth of this product segment.

“The preclinical applications segment is projected to register the highest CAGR during the forecast period”

Based on application, the near infrared imaging market is broadly categorized into preclinical, clinical and medical. Preclinical imaging refers to the visualization of living animals for research purposes, such as for drug development. It helps scientists to detect and monitor biological mechanisms and to accurately measure and provide therapeutic responses within the body. The growing focus on developing new treatments for diseases/conditions such as cancer, inflammation, angiogenesis, infections, and vascular diseases is expected to drive the growth of this application segment during the forecast period.

“The cancer surgeries segment is projected to register the highest CAGR during the forecast period”

Based on procedure, the near infrared imaging market is broadly categorized into cancer surgeries, gastrointestinal surgeries, cardiovascular surgeries, plastic/reconstructive surgeries, and brain tumor surgeries. The rising prevalence of cancer across the globe is the major factor driving the growth of this segment.

“The market in the North America region is expected to witness the highest growth during the forecast period.”

The near infrared imaging market in the North America region is expected to register a CAGR during the forecast period, primarily due to the high healthcare spending in the region, rising prevalence of target diseases, increasing research activities, growing number of cosmetic surgeries, and technological advancements in imaging systems.

A breakdown of the primary participants referred to for this report is provided below:
  • By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
  • By Designation: Director-level–14%, C-level–10%, and Others–76%
  • By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
The prominent players in the near infrared imaging market are Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), LI-COR, Inc. (US), Medtronic (Ireland) among others.

Research Coverage

This report studies the near infrared imaging market based on product, procedure, application, enduser, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall near infrared imaging market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:
  • Analysis of key drivers (rising target patient population, growing adoption of multimodal PET imaging devices, technological advancement, and increasing investment, funds, and grants by public-private organizations), restraints (high capital and operational cost, unfavorable regulatory guidelines), opportunities (improving healthcare infrastructure across emerging countries, PET utilization for breast imaging, promising product pipeline), and challenges (availability of alternate imaging technologies) influencing the growth of the near infrared imaging market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the near infrared imaging market
  • Market Development: Comprehensive information about lucrative markets–the report analyses the near infrared imaging market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the near infrared imaging market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), LI-COR, Inc. (US), and Medtronic (Ireland).
1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
  1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKETS COVERED
  1.3.1 MARKET SEGMENTATION
  1.3.2 REGIONAL SEGMENTATION
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 RESEARCH LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 1 NEAR INFRARED IMAGING MARKET: RESEARCH DESIGN
  2.1.1 SECONDARY RESEARCH
  2.1.2 PRIMARY RESEARCH
    2.1.2.1 Primary sources
    2.1.2.2 Key industry insights
    2.1.2.3 Breakdown of primaries
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  2.2.1 BOTTOM-UP APPROACH
    2.2.1.1 Approach 1: Company revenue estimation approach
FIGURE 5 APPROACH 1: MARKET SIZE ESTIMATION (COMPANY REVENUE ESTIMATION)
FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF STRYKER
    2.2.1.2 Approach 2: Customer-based market estimation
FIGURE 7 NEAR-INFRARED IMAGING MARKET: BOTTOM-UP APPROACH
    2.2.1.3 CAGR projections
FIGURE 8 CAGR PROJECTION: SUPPLY SIDE ANALYSIS
2.3 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ASSESSMENT
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
  2.6.1 NEAR-INFRARED IMAGING MARKET: RISK ASSESSMENT
2.7 GROWTH RATE ASSUMPTIONS
2.8 NEAR-INFRARED IMAGING MARKET: RECESSION IMPACT

3 EXECUTIVE SUMMARY

FIGURE 10 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 11 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 12 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023 VS. 2028 (USD MILLION)
FIGURE 13 NEAR-INFRARED IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT: NEAR-INFRARED IMAGING MARKET

4 PREMIUM INSIGHTS

4.1 NEAR-INFRARED IMAGING MARKET OVERVIEW
FIGURE 15 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET
4.2 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT (2023 VS. 2028)
FIGURE 16 DEVICES SEGMENT TO DOMINATE NORTH AMERICAN NEAR-INFRARED IMAGING MARKET DURING FORECAST PERIOD
4.3 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER (2023 VS. 2028)
FIGURE 17 HOSPITALS & SURGICAL CLINICS TO FORM LARGEST END USER SEGMENT IN ASIA PACIFIC MARKET
4.4 GLOBAL: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE (2023 VS. 2028)
FIGURE 18 FLUORESCENCE IMAGING SYSTEMS SEGMENT TO HOLD LARGEST SHARE DURING STUDY PERIOD
4.5 GEOGRAPHICAL SNAPSHOT OF NEAR-INFRARED IMAGING MARKET
FIGURE 19 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 NEAR-INFRARED IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  5.2.1 DRIVERS
    5.2.1.1 Increasing number of surgical procedures globally
    5.2.1.2 Advantages of near-infrared imaging over conventional visualization methods
TABLE 1 ADVANTAGES OF NEAR-INFRARED IMAGING OVER CONVENTIONAL VISUALIZATION METHODS
    5.2.1.3 Technological advancements in near-infrared imaging modalities
    5.2.1.4 Adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging
  5.2.2 RESTRAINTS
    5.2.2.1 Lengthy approval process of near-infrared fluorophores
    5.2.2.2 High initial capital and operational costs of near-infrared systems
    5.2.2.3 Availability of alternate technologies
  5.2.3 OPPORTUNITIES
    5.2.3.1 Growth potential for major players in emerging economies
    5.2.3.2 Use of blockchain for distribution and storage of medical images
  5.2.4 CHALLENGES
    5.2.4.1 Hospital budget cuts
    5.2.4.2 Dearth of trained professionals in emerging economies
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 NEAR-INFRARED IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
  5.3.1 THREAT OF NEW ENTRANTS
  5.3.2 THREAT OF SUBSTITUTES
  5.3.3 BARGAINING POWER OF SUPPLIERS
  5.3.4 BARGAINING POWER OF BUYERS
  5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 REGULATORY ANALYSIS
  5.4.1 NORTH AMERICA
    5.4.1.1 US
TABLE 3 US: APPROVED IMAGING DEVICES BY FDA
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    5.4.1.2 Canada
TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  5.4.2 EUROPE
  5.4.3 ASIA PACIFIC
    5.4.3.1 Japan
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
    5.4.3.2 China
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES
    5.4.3.3 India
5.5 REIMBURSEMENT SCENARIO ANALYSIS
TABLE 9 MEDICAL REIMBURSEMENT CPT CODES FOR NEAR-INFRARED PROCEDURES IN US (AS OF 2021)
5.6 ECOSYSTEM MAPPING
5.7 VALUE CHAIN ANALYSIS
  5.7.1 RESEARCH & PRODUCT DEVELOPMENT
  5.7.2 RAW MATERIAL AND MANUFACTURING
  5.7.3 MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES
FIGURE 21 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.8 SUPPLY CHAIN ANALYSIS
  5.8.1 PROMINENT COMPANIES
  5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES
  5.8.3 END USERS
TABLE 10 SUPPLY CHAIN ECOSYSTEM OF NEAR-INFRARED IMAGING MARKET
FIGURE 22 NEAR-INFRARED IMAGING MARKET: SUPPLY CHAIN ANALYSIS
5.9 PATENT ANALYSIS
FIGURE 23 PATENT DETAILS FOR NEAR-INFRARED IMAGING (JANUARY 2013–MAY 2023)
FIGURE 24 PATENT DETAILS FOR NEAR-INFRARED FLUORESCENCE IMAGING SYSTEMS (JANUARY 2013–MAY 2023)
FIGURE 25 PATENT DETAILS FOR NEAR-INFRARED DYES (JANUARY 2013–MAY 2023)
5.10 TRADE ANALYSIS
  5.10.1 TRADE ANALYSIS: NEAR-INFRARED IMAGING MARKET
TABLE 11 IMPORT DATA FOR NEAR-INFRARED IMAGING (HS CODE 902750), BY COUNTRY, 2018–2022 (USD)
TABLE 12 EXPORT DATA FOR NEAR-INFRARED IMAGING (HS CODE 902750), BY COUNTRY, 2018–2022 (USD)
5.11 KEY CONFERENCES AND EVENTS (2023–2025)
TABLE 13 NEAR-INFRARED IMAGING MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2025)
5.12 TECHNOLOGY ANALYSIS
5.13 CASE STUDY ANALYSIS
  5.13.1 TECHNOLOGICAL CHALLENGES
TABLE 14 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE
  5.13.2 LOWERING DEPENDENCE ON CONTRACT MANUFACTURING
TABLE 15 CASE STUDY 2: PROVIDING TRAINING AND EDUCATION AND KEEPING UP WITH EVOLVING SURGICAL TECHNIQUES
5.14 PRICING ANALYSIS
TABLE 16 REGION-WISE PRICE RANGE FOR NEAR-INFRARED IMAGING SYSTEMS

6 NEAR-INFRARED IMAGING MARKET, BY PRODUCT

6.1 INTRODUCTION
TABLE 17 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 DEVICES
TABLE 18 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 19 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY REGION, 2021–2028 (USD MILLION)
TABLE 20 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 21 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 22 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY END USER, 2021–2028 (USD MILLION)
  6.2.1 FLUORESCENCE IMAGING SYSTEMS
    6.2.1.1 Higher sensitivity and better real-time image guidance during surgeries to drive market
TABLE 23 FLUORESCENCE IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
  6.2.2 FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS
    6.2.2.1 Better sensitivity and higher efficiency at lower costs to drive market
TABLE 24 FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 NIR IMAGING AGENTS/PROBES
TABLE 25 NEAR-INFRARED IMAGING MARKET FOR NIR IMAGING AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 26 NEAR-INFRARED IMAGING MARKET FOR NIR IMAGING AGENTS/PROBES, BY REGION, 2021–2028 (USD MILLION)
TABLE 27 NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 28 NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 29 NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY END USER, 2021–2028 (USD MILLION)
  6.3.1 INDOCYANINE GREEN
    6.3.1.1 Increasing utilization of small organic probes in near-infrared imaging to drive segment
TABLE 30 INDOCYANINE GREEN MARKET, BY REGION, 2021–2028 (USD MILLION)
  6.3.2 OTHER REAGENTS
    6.3.2.1 Other reagents to provide specific functionalities and properties for better imaging process
TABLE 31 OTHER REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4 NIR DYES
TABLE 32 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 33 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY REGION, 2021–2028 (USD MILLION)
TABLE 34 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 35 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 36 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY END USER, 2021–2028 (USD MILLION)
  6.4.1 ORGANIC DYES
    6.4.1.1 Unique molecular structure and better compatibility with biological systems to drive segment
TABLE 37 ORGANIC DYES MARKET, BY REGION, 2021–2028 (USD MILLION)
  6.4.2 NANOPARTICLE DYES
    6.4.2.1 Better brightness and enhanced signal intensity compared to organic dyes to drive segment
TABLE 38 NANOPARTICLE DYES MARKET, BY REGION, 2021–2028 (USD MILLION)

7 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE

7.1 INTRODUCTION
TABLE 39 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
7.2 CANCER SURGERIES
TABLE 40 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 41 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY REGION, 2021–2028 (USD MILLION)
  7.2.1 BRAIN CANCER/TUMOR SURGERIES
    7.2.1.1 Advancements in surgical navigation using NIR-I/II fluorescence imaging to drive market
TABLE 42 BRAIN CANCER/TUMOR SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION)
  7.2.2 OTHER CANCER SURGERIES
    7.2.2.1 Better tissue penetration and lower autofluorescence levels to drive market
TABLE 43 OTHER CANCER SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 GASTROINTESTINAL SURGERIES
TABLE 44 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 45 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY REGION, 2021–2028 (USD MILLION)
  7.3.1 COLORECTAL SURGERIES
    7.3.1.1 Advancements in treatment strategies and procedures to drive market
TABLE 46 COLORECTAL SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION)
  7.3.2 OTHER GASTROINTESTINAL SURGERIES
    7.3.2.1 Precise visualization of near-infrared imaging to drive market
TABLE 47 OTHER GASTROINTESTINAL SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4 CARDIOVASCULAR DISEASES
  7.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES AMONG ALL AGE GROUPS TO DRIVE MARKET
TABLE 48 NEAR-INFRARED IMAGING MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION)
7.5 PLASTIC/RECONSTRUCTIVE SURGERIES
  7.5.1 RISING NUMBER OF RECONSTRUCTIVE SURGERIES GLOBALLY TO DRIVE MARKET
TABLE 49 NEAR-INFRARED IMAGING MARKET FOR PLASTIC/RECONSTRUCTIVE SURGERIES, BY REGION, 2021–2028 (USD MILLION)
7.6 OBSTETRICS & GYNECOLOGY SURGERIES
  7.6.1 INCREASED NUMBER OF CLINICAL TRIALS AND IMPROVED TISSUE CONTRAST DURING SURGERIES TO DRIVE MARKET
TABLE 50 NEAR-INFRARED IMAGING MARKET FOR OBSTETRICS & GYNECOLOGY SURGERIES, BY REGION, 2021–2028 (USD MILLION)
7.7 OTHER PROCEDURES
TABLE 51 NEAR-INFRARED IMAGING MARKET FOR OTHER PROCEDURES, BY REGION, 2021–2028 (USD MILLION)

8 NEAR-INFRARED IMAGING MARKET, BY APPLICATION

8.1 INTRODUCTION
TABLE 52 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 PRECLINICAL IMAGING
  8.2.1 GROWING FOCUS ON DEVELOPING NEW TREATMENTS FOR CHRONIC DISEASES TO DRIVE MARKET
TABLE 53 NEAR-INFRARED IMAGING MARKET FOR PRECLINICAL IMAGING, BY REGION, 2021–2028 (USD MILLION)
8.3 CLINICAL IMAGING
  8.3.1 INCREASING USE OF NEAR-INFRARED IMAGING FOR REAL-TIME VISUALIZATION DURING SURGERIES TO DRIVE MARKET
TABLE 54 NEAR-INFRARED IMAGING MARKET FOR CLINICAL IMAGING, BY REGION, 2021–2028 (USD MILLION)
8.4 MEDICAL IMAGING
  8.4.1 APPLICATIONS OF FLUORESCENCE IMAGING SINGLE-CELL TRACKING FOR STUDYING IMMUNE SYSTEM TO DRIVE MARKET
TABLE 55 NEAR-INFRARED IMAGING MARKET FOR MEDICAL IMAGING, BY REGION, 2021–2028 (USD MILLION)

9 NEAR-INFRARED IMAGING MARKET, BY END USER

9.1 INTRODUCTION
TABLE 56 NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 HOSPITALS & SURGICAL CLINICS
  9.2.1 RISING NUMBER OF CANCER AND RECONSTRUCTIVE SURGERIES TO DRIVE MARKET
TABLE 57 NEAR-INFRARED IMAGING MARKET FOR HOSPITALS & SURGICAL CLINICS, BY REGION, 2021–2028 (USD MILLION)
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  9.3.1 GROWING PRECLINICAL RESEARCH AND DRUG DISCOVERY TO DRIVE MARKET
TABLE 58 NEAR-INFRARED IMAGING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION)
9.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
  9.4.1 FUNDING FROM GOVERNMENT ORGANIZATIONS FOR BIOMEDICAL RESEARCH TO DRIVE MARKET
TABLE 59 NEAR-INFRARED IMAGING MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
9.5 OTHER END USERS
TABLE 60 NEAR-INFRARED IMAGING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)

10 NEAR-INFRARED IMAGING MARKET, BY REGION

10.1 INTRODUCTION
TABLE 61 NEAR-INFRARED IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET SNAPSHOT
TABLE 62 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 64 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 66 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 67 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 68 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 69 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.2.1 US
    10.2.1.1 Advanced healthcare infrastructure and favorable regulations to drive market
TABLE 70 US: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 71 US: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 72 US: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 73 US: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
  10.2.2 CANADA
    10.2.2.1 Increased availability of research funding to drive market
TABLE 74 CANADA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 75 CANADA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 76 CANADA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 77 CANADA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.3 EUROPE
TABLE 78 EUROPE: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 80 EUROPE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 81 EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 82 EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 83 EUROPE: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 84 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 85 EUROPE: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.1 GERMANY
    10.3.1.1 Increasing healthcare expenditure and government spending to drive market
TABLE 86 GERMANY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 87 GERMANY: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 88 GERMANY: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 89 GERMANY: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
  10.3.2 FRANCE
    10.3.2.1 Increasing target patient population and rising number of diagnostic tests for chronic diseases to drive market
TABLE 90 FRANCE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 91 FRANCE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 92 FRANCE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 93 FRANCE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
  10.3.3 UK
    10.3.3.1 Growing government initiatives and increasing incidences of chronic diseases to drive market
TABLE 94 UK: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 95 UK: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 96 UK: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 97 UK: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
  10.3.4 ITALY
    10.3.4.1 Increased availability of reimbursement coverage for diagnostic procedures to drive market
TABLE 98 ITALY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 99 ITALY: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 100 ITALY: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 101 ITALY: NEAR-INFRARED IMAGING MARKET FOR NIR DYE, BY TYPE, 2021–2028 (USD MILLION)
  10.3.5 SPAIN
    10.3.5.1 Increasing prevalence of cancer and growing private-public funding to drive market
TABLE 102 SPAIN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 103 SPAIN: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 SPAIN: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 SPAIN: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
  10.3.6 REST OF EUROPE
TABLE 106 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 107 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 108 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 109 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET SNAPSHOT
TABLE 110 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 112 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 116 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 117 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.4.1 CHINA
    10.4.1.1 Increasing healthcare reforms and government investments to drive market
TABLE 118 CHINA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 119 CHINA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 CHINA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 CHINA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
  10.4.2 JAPAN
    10.4.2.1 Fast adoption of advanced technologies and growth in geriatric population to drive market
TABLE 122 JAPAN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 123 JAPAN: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 124 JAPAN: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 125 JAPAN: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
  10.4.3 INDIA
    10.4.3.1 Increasing number of diagnostic procedures and improving healthcare infrastructure to drive market
TABLE 126 INDIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 127 INDIA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 INDIA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 129 INDIA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
  10.4.4 AUSTRALIA
    10.4.4.1 Growing healthcare spending and increasing investments in research to drive market
TABLE 130 AUSTRALIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 131 AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 133 AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
  10.4.5 SOUTH KOREA
    10.4.5.1 Presence of advanced healthcare system and increased awareness about diseases to drive market
TABLE 134 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 135 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
  10.4.6 REST OF ASIA PACIFIC
TABLE 138 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 139 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.5 LATIN AMERICA
TABLE 142 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 144 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 147 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 148 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 149 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.5.1 BRAZIL
    10.5.1.1 Greater purchasing power and more favorable demographic conditions to drive market
TABLE 150 BRAZIL: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 151 BRAZIL: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 152 BRAZIL: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 153 BRAZIL: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
  10.5.2 MEXICO
    10.5.2.1 Increased medical tourism and better government healthcare initiatives to drive market
TABLE 154 MEXICO: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 155 MEXICO: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 MEXICO: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 MEXICO: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
  10.5.3 REST OF LATIN AMERICA
TABLE 158 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 159 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 160 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
  10.6.1 GROWING MEDICAL TOURISM TO DRIVE MARKET
TABLE 162 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 163 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 164 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 165 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 166 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 167 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
  11.2.1 OVERVIEW OF KEY STRATEGIES ADOPTED BY PLAYERS IN NEAR-INFRARED IMAGING MARKET
11.3 REVENUE SHARE ANALYSIS
FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN NEAR-INFRARED IMAGING MARKET, 2022
11.4 MARKET SHARE ANALYSIS
FIGURE 29 MARKET SHARE ANALYSIS OF TOP PLAYERS IN NEAR-INFRARED IMAGING MARKET, 2022
TABLE 169 NEAR-INFRARED IMAGING MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
  11.5.1 STARS
  11.5.2 EMERGING LEADERS
  11.5.3 PERVASIVE PLAYERS
  11.5.4 PARTICIPANTS
FIGURE 30 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
  11.6.1 PROGRESSIVE COMPANIES
  11.6.2 STARTING BLOCKS
  11.6.3 RESPONSIVE COMPANIES
  11.6.4 DYNAMIC COMPANIES
FIGURE 31 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.7 COMPETITIVE BENCHMARKING
TABLE 170 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF KEY PLAYERS
TABLE 171 PRODUCT FOOTPRINT OF COMPANIES
TABLE 172 GEOGRAPHICAL FOOTPRINT OF COMPANIES
11.8 COMPETITIVE SCENARIOS AND TRENDS
TABLE 173 KEY PRODUCT LAUNCHES
TABLE 174 KEY DEALS
TABLE 175 OTHER KEY DEVELOPMENTS

12 COMPANY PROFILES

(Business overview, Products offered, Recent developments & MnM View)*
12.1 KEY PLAYERS
  12.1.1 STRYKER
TABLE 176 STRYKER: COMPANY OVERVIEW
FIGURE 32 STRYKER: COMPANY SNAPSHOT (2022)
  12.1.2 KARL STORZ SE & CO. KG
TABLE 177 KARL STORZ SE & CO. KG: COMPANY OVERVIEW
  12.1.3 CARL ZEISS MEDITEC AG
TABLE 178 CARL ZEISS MEDITEC GROUP: COMPANY OVERVIEW
FIGURE 33 CARL ZEISS MEDITEC GROUP: COMPANY SNAPSHOT (2022)
  12.1.4 LEICA MICROSYSTEMS
TABLE 179 LEICA MICROSYSTEMS: COMPANY OVERVIEW
FIGURE 34 LEICA MICROSYSTEMS (DANAHER CORPORATION): COMPANY SNAPSHOT (2022)
  12.1.5 OLYMPUS CORPORATION
TABLE 180 OLYMPUS CORPORATION: COMPANY OVERVIEW
FIGURE 35 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
  12.1.6 SHIMADZU CORPORATION
TABLE 181 SHIMADZU CORPORATION: COMPANY OVERVIEW
FIGURE 36 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2021)
  12.1.7 PERKINELMER, INC.
TABLE 182 PERKINELMER, INC.: COMPANY OVERVIEW
FIGURE 37 PERKINELMER, INC.: COMPANY SNAPSHOT (2021)
  12.1.8 LI-COR, INC.
TABLE 183 LI-COR, INC.: COMPANY OVERVIEW
  12.1.9 HAMAMATSU PHOTONICS K.K.
TABLE 184 HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW
FIGURE 38 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2022)
  12.1.10 QUEST MEDICAL IMAGING B.V.
TABLE 185 QUEST MEDICAL IMAGING B.V.: COMPANY OVERVIEW
  12.1.11 SIGMA-ALDRICH (MERCK)
TABLE 186 SIGMA-ALDRICH: COMPANY OVERVIEW
FIGURE 39 SIGMA-ALDRICH: COMPANY SNAPSHOT (2022)
  12.1.12 MIZUHO MEDICAL CO., LTD.
TABLE 187 MIZUHO MEDICAL CO., LTD.: COMPANY OVERVIEW
  12.1.13 TELEDYNE PRINCETON INSTRUMENTS
TABLE 188 TELEDYNE PRINCETON INSTRUMENTS: COMPANY OVERVIEW
FIGURE 40 TELEDYNE PRINCETON INSTRUMENTS: COMPANY SNAPSHOT (2022)
  12.1.14 THERMO FISHER SCIENTIFIC INC.
TABLE 189 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
  12.1.15 FLUOPTICS
TABLE 190 FLUOPTICS: COMPANY OVERVIEW
  12.1.16 MEDTRONIC
TABLE 191 MEDTRONIC: COMPANY OVERVIEW
  12.1.17 CAYMAN CHEMICAL
TABLE 192 CAYMAN CHEMICAL: COMPANY OVERVIEW
  12.1.18 MP BIOMEDICALS
TABLE 193 MP BIOMEDICALS: COMPANY OVERVIEW
  12.1.19 CRYSTA-LYN CHEMICAL COMPANY
TABLE 194 CRYSTA-LYN CHEMICAL COMPANY: COMPANY OVERVIEW
  12.1.20 GOWERLABS LTD.
TABLE 195 GOWERLABS LTD.: COMPANY OVERVIEW
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12.2 OTHER COMPANIES
  12.2.1 NIRX MEDICAL TECHNOLOGIES, LLC
  12.2.2 XENICS NV
  12.2.3 BIOTIUM
  12.2.4 TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD.
  12.2.5 AAT BIOQUEST, INC.

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS


More Publications